tapentadol neuropathy
Selected indexed studies
- Diabetic peripheral neuropathy essentials: a narrative review. (Ann Palliat Med, 2023) [PMID:36786097]
- Diabetic Neuropathy: A Guide to Pain Management. (Curr Pain Headache Rep, 2024) [PMID:38967712]
- Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. (Diabetes Metab J, 2023) [PMID:37670573]
_Worker-drafted node — pending editorial review._
Connections
tapentadol neuropathy is a side effect of
Sources
- Diabetic peripheral neuropathy essentials: a narrative review. (2023) pubmed
- Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy. (2023) pubmed
- Gabapentin for chronic neuropathic pain in adults. (2017) pubmed
- Evolving Treatment Strategies for Neuropathic Pain: A Narrative Review. (2025) pubmed
- Diabetic Neuropathy: A Guide to Pain Management. (2024) pubmed
- Evidence-Based Treatment of Painful Diabetic Neuropathy: a Systematic Review. (2022) pubmed
- Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options. (2024) pubmed
- Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy. (2014) pubmed
- Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial. (2022) pubmed
- State-of-the-art pharmacotherapy for diabetic neuropathy. (2021) pubmed